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Monday, February 9, 2015 199athe architecture of this polymer and to reveal novel insights into its biosynthesis
and hydrolysis. Atomic force microscopy has demonstrated a complex, nano-
scale peptidoglycan architecture in diverse species, which meets the challenges
of maintaining viability and growth within their environmental niches by
exploiting the bioengineering versatility of the polymer. The application of
super-resolution fluorescence microscopy, coupled with new chemical probes
has begun to reveal how this essential polymer is synthesized during growth
and division.
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In eukaryotes and bacteria, chromosome organization and segregation needs to
be carefully orchestrated to ensure faithful transmission of genetic material dur-
ing cell division. The molecular mechanisms responsible for bacterial chromo-
some organization and segregation remain elusive, possibly because these
processes are highly influenced by the action of many DNA processes overlap-
ping in time and space (e.g. replication, transcription, or repair). Here, we
investigate the higher-order organization of DNA in a fast replicating bacte-
rium by using a combination of chromosome-capture technologies and super-
resolution microscopies. First, we found that specific topological barriers act
to separate the chromosome into specific higher-order domains at different
length-scales. Notably, higher-order domains are visible in single cells and
their number increases with cell cycle progression in a step-wise manner.
The number of topological domains and their genetic and cellular localization
strictly depend on transcriptional activity. Secondly, we found that replication
severely affects the three-dimensional organization of the chromosome and
determined the molecular factors involved in this replication-induced re-orga-
nization. Finally, we determined the ultra-structural organization and dynam-
ical behaviour of replication domains and their role in chromosome
organization and segregation.Symposium: Neurotransmitter Transporters
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Glutamate transporters are responsible for the clearance of the neurotransmitter
glutamate from the synaptic cleft following rounds of neurotransmission. They
couple the uptake of glutamate into the cytoplasm of glial cells and neurons to
symport of sodium ions and protons and to antiport of a potassium ion. We have
investigated the molecular mechanism of this family of transporters using an
archaeal homologue, aspartate and sodium symporter GltPh, as a model system.
For GltPh, we obtained crystal structures of key functional states along the
transport cycle and probed the dynamics and thermodynamics that define the
rates of substrate uptake and the mechanism of coupling the uptake to move-
ments of ions.
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Excitatory amino acid transporters (EAATs) and neutral amino acid trans-
porters (ASCTs) belong to the solute carrier 1 (SLC1) family of transport pro-
teins. While EAATs transport the excitatory amino acid, glutamate, into cells
driven by the transmembrane electrochemical concentration gradient of Naþ,
ASCTs function as exchangers, taking up neutral amino acid in homo- or
hetero-exchange with intracellular amino acid in a Naþ-dependent manner.
Despite these functional differences, mechanism of transmembrane movement
of amino acid appears to be conserved in these transporters. For example, Naþ/
substrate translocation is electrogenic in both transporters and electrostatics of
charge balance are preserved by specific alterations to key charged amino acid
residues. Here, we discuss results from kinetic experiments that reveal the time
dependence of the translocation process down to the sub-millisecond time
range, demonstrating dynamic behavior that spans 2 orders of magnitude.
The results allow the dissection of individual reaction steps in the transport cy-
cle, explaining voltage-dependent behavior with electrostatic calculations
based on structural models.999-Symp
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Synaptic transmission is regulated by the coordinated action of neurotransmitter
release and reuptake. Specialized secondary-active neurotransmitter transporter
proteins mediate the presynaptic reuptake of the respective neurotransmitters.
Thereby, transporters re-accumulate the neurotransmitter in an economical
fashion from the synaptic cleft into the presynaptic specialization by using the
pre-established sodium gradient as a driving force. Two major classes can be
distinguished: The During the last decade, crystal structures of archeal homo-
logues of mammalian transporters have been published in various states. These
structures serve as starting templates to study the structure function relationship
in the mammalian counterparts. Hence, we combine molecular dynamics simu-
lations and homology modeling with Lanthanide resonance energy transfer
(LRET) measurements to explore substrate translocation in bacterial and
mammalian transporters in a triangulated manner. We use the leucine/alanine
transporter from Aquifex aeolicus (LeuTAa), the aspartate transporter from
Pyrococcus horikoshi (GltPh) and the mammalian excitatory amino acid trans-
porter 3 (EAAT3) and complement our key findings using biochemical studies.
Using this multi-facetted approach allows us to ascertain the molecular move-
ments of neurotransmitter transporters and their bacterial homologues and
compare our results to the results obtained in crystallization experiments.
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Transporters act over wide ranges of time and space in the brain: they help pre-
vent excitotoxicity by limiting tonic NMDA receptor activation, and in addition
they maintain the specificity of neuronal communication by limiting spillover
of synaptically released glutamate. In this work we show how small changes in
transporter density can lead to supralinear changes in ambient extracellular
glutamate, which may play a role in certain neuropathologies. In addition,
we show data suggesting that the role of transporters in limiting NMDA recep-
tor activity during synaptic transmission is complex and depends strongly on
the frequency of synaptic activity. We show that in physiological conditions,
Mg2þ block rather than glutamate transport plays a dominant role in restricting
NMDA receptor activity during low frequency activity. During higher fre-
quency activity, including frequency ranges associate with induction of long-
term potentiation and learning, a pool of glutamate-bound and Mg2þ-blocked
NMDARs signal in a phase-shifted manner governed by glutamate transport.Platform: Cardiac Muscle Mechanics and
Structure
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Background: ADP-stimulated tension can develop in skinned myocytes from
animals in the absence of Ca. It is, however, unknown whether these effects
impair the human heart, where energetic imbalance causes high ADP. More-
over, the free Ca transient range in cardiomyocytes varies during HF, which
suggests that cytosolic changes of ADP are likely in concert with changes in
intracellular Ca. Here, we provide evidence that physiological ADP (20 and
100 mM) accumulation may link myocardial energetics and contractile dysfunc-
tion in the failing human heart.
Methods: Force measurements were performed in single skinned myocytes iso-
lated from failing human hearts at sarcomere length of 2.2 mm. Cells were acti-
vated in solutions containing: 1) ADP (without Ca); 2) Ca (without ADP) and
3) Ca in the presence of ADP. Moreover, cross-bridge cycling kinetics was
assessed. Exogenous protein kinase A (PKA)-treatment was performed to
200a Monday, February 9, 2015determine whether myofilaments activated with ADP (without Ca) are sensitive
to kinase treatment.
Results:We show thatADP, in the absence ofCa, accelerates cross-bridge cycling
and force development in cardiomyocytes from HF patients, which was sensitive
to PKA-mediated phosphorylation (i.e. decreased sensitivity to ADP). Ca-
sensitivity increased in the presence of increasing [ADP] and was accompanied
by significant slowing cross-bridge cycling kinetics. This was correlatedwith sig-
nificant increases in residual force enhancement (i.e. high initial tension recovery).
Conclusions: The current data show that high [ADP] reduces the ability to
desensitize myofilaments to Ca, which likely compromises restoration of
end-diastolic length. High ADP increased cross-bridge strain (i.e. diastolic
dysfunction) and depressed myofilament cycling kinetics, which may limit
muscle shortening (i.e. systolic dysfunction). The present study suggests that
inability to lower myocardial ADP levels can be a primary determinant of con-
tractile dysfunction and disease progression in human HF.
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Slow myocardial relaxation is an important clinical problem in about 50% of
patients who have heart failure. Prior experiments had suggested that the
slow relaxation might be a consequence of high afterload (hypertension) but
large clinical trials testing this hypothesis have failed; lowering blood pressure
in patients who have heart failure with preserved ejection fraction does not help
clinical outcomes. We performed new experiments using mouse, rat, and hu-
man trabeculae (Chung et al., Biophys J. 106,564a, 2014) and showed that it
is not afterload but the strain rate at end systole that determines the subsequent
speed of relaxation. To investigate the molecular mechanisms that drive this
behavior, we ran simulations of our mechanical experiments using the freely
available software MyoSim (http://www.myosim.org). This software simulates
the mechanical properties of dynamically activated half-sarcomeres by extend-
ing A.F.Huxley’s cross-bridge distribution technique with calcium activation
and cooperative effects. We discovered that our experimental data could be
reproduced using a relatively simple framework consisting of a single half-
sarcomere pulling against a series elastic spring. Further analysis of the simu-
lations suggested that quick stretches speed myocardial relaxation by detaching
myosin heads and thereby disrupting the cooperative mechanisms that would
otherwise prolong thin filament activation. The simulations therefore identify
myofilament kinetics and tissue strain rate as potential therapeutic targets for
heart failure attributed to slow relaxation.
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Cardiac contractility increases as sarcomere length (SL) increases, suggesting
that intrinsic molecular mechanisms underlie the Frank-Starling relationship
to confer increased cardiac output with greater ventricular filling. Myosin’s ca-
pacity to generate force is Ca2þ-regulated by thin-filament proteins and sarco-
mere length, which dictates the number of potential actin-myosin cross-bridge
interactions. One mechanism underlying greater cardiac contractility at longer
SL could involve longer myosin attachment duration (ton). To test this idea, we
used stochastic length-perturbation analysis in skinned rat papillary muscle
strips to measure ton as [MgATP] varied (0.05-5 mM) at 1.9 and 2.2 mm SL.
From this ton-MgATP relationship, we calculated cross-bridge MgADP release
rate (k-ADP) and MgATP binding rate (kþATP). As MgATP increased ton
decreased hyperbolically for both SL, but ton was roughly 50% longer for
2.2 vs. 1.9 mm SL at each [MgATP] (2553 vs. 1651 ms at 5 mM MgATP,
17 C, p<0.05). These ton differences arose from slower k-ADP at 2.2 mm SL
(4253 vs. 7458 s1, p<0.001), as MgATP binding rates did not differ with
SL (281556 vs. 327593 mM1 s1). Absolute tension values were greater
at 2.2 vs. 1.9 mm SL for relaxed (4.450.7 vs. 0.850.2 kPa at pCa 8.0,
p<0.001) and maximally activated (20.051.4 vs. 14.251.6 kPa at pCa 4.8,
p<0.001) conditions, and the force-pCa relationship was more sensitive to
Ca2þ at 2.2 mm SL (pCa50¼5.4550.01 vs. 5.3650.01, p<0.05). These
increased tension values suggest that cross-bridges may bear greater loads at
longer SL, which diminishes MgADP release to prolong ton and amplify coop-
erative cross-bridge contributions to thin filament activation. Therefore, load-
dependent rates of the actomyosin cross-bridge cycle may vary with SL to
contribute, in part, to the Frank-Starling relationship in the heart.1004-Plat
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The cardiac cycle is a tightly regulated process in which the heart generates po-
wer during systole and relaxes during diastole. Appropriate power must be
generated to effectively pump blood against cardiac afterload. Dysfunction
of this cycle has devastating consequences for affected individuals. Cardiac po-
wer output is regulated by several feedback mechanisms (e.g. neuronal, hor-
monal, mechanical) which ultimately lead to changes in the force and power
output of the molecular motor, b-cardiac myosin (bCM). Despite its importance
in driving and regulating cardiac power output, the effect of force on the
contractility of a single bCM has not been measured at physiological [ATP].
Using optical trapping techniques, we found that similar to some other myosins,
bCM has a two-substep working stroke where the second mechanical substep is
associated with ADP release. At saturating [ATP] (4 mM), forces that resist the
power stroke slow myosin-driven contraction, suggesting that the inherent
properties of myosin contribute to the force-velocity relationship in muscle
and play an important role in the regulation of cardiac power output. Based
on our results and kinetic modeling, we propose that force inhibits the mechan-
ical transition associated with ADP release, leading to slowing of the rate of
ADP release, the same kinetic step that limits muscle shortening. These results
have important implications for cardiac diseases which affect power output,
such as heart failure and cardiomyopathies. This work was supported by the
American Heart Association (14SDG18850009 to M.J.G.) and National Insti-
tutes of Health (R01GM057247 to E.M.O. and K99HL123623 to M.J.G.).
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A significant number of cardiac myopathies in children and adults are caused
by mutations in the cMyBP-C gene. In disease, cardiac output is compromised
by altered cardiac muscle fiber contractility due to modulated interactions be-
tween cMyBP with actin or with S2. Comparative measurements in WT and
knockout mice (cMyBP-C-/-) muscle fibers have showed increased isotonic
shortening velocity, power output and rate of force redevelopment in absence
cMyBP-C. Thus, change of only a few amino acids in mutant cMyBP-C, espe-
cially in regions rich with phosphorylation sites, may cause significant change
in dynamics of muscle contractility. Comparison of measured sliding velocities
of actin filaments over the regions of myosin filament with and without
cMyBP-C in motility assays have provided molecular insight how these struc-
tural changes alter the kinetics of the interactions of cMyBP-C with myosin and
actin filaments. We used a multi-scale, computational modelling platform,
MUSICO, (MUscle SImulation COde) to assess the effect of cMyBP-C muta-
tions on sarcomere contraction. This platform includes explicit 3-D sarcomere
structures, extensible actin and myosin filaments, various models for the acto-
myosin cycles, thin filament regulation via a continuous flexible chain (CFC)
model and now cMyBP-C using the kinetic parameters for dynamically form-
ing and disrupting connections between cMyBP-C and actin, derived from the
motility studies. We compared the model predictions between different muta-
tions and the corresponding mechanical experiments. The predictions from
cMyBP-C sarcomeric model showed significant differences between the mu-
tants, and closely followed observations. This results allow the quantitative
evaluation of the role of cMyBP-C in the regulation of sarcomere structure
and function, the development of a multi-scale myoarchitectural representation
of disease phenotype and the creation of a novel diagnostic and prognostic
methodology for tracking disease progression in patients.
Supported by: R01s AR048776 and DC 011528
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